Straumann Holding AG (SAUHY) Stock

About Straumann Holding AG

Straumann Holding AG is a leading global provider of comprehensive dental solutions, specializing in tooth restoration, replacement, and orthodontic treatment. The company actively engages in the research, development, production, and distribution of a diverse portfolio of dental products. This range encompasses advanced dental implants, precision instruments, CAD/CAM prosthetics, clear orthodontic aligners, biomaterials, and cutting-edge digital technologies. These offerings are designed to facilitate tooth correction, replacement, and restoration, while also playing a role in preventing future tooth loss. Straumann's core product lines include a wide array of dental implant systems, featuring tissue and bone level options crafted from materials like titanium, titanium alloy, and ceramics, alongside specialized mini-implants. The company also supplies a full suite of surgical instruments, both guided and non-guided, vital for implant procedures, as well as various implant-supported prosthetics. It excels in digital dentistry, offering sophisticated intraoral scanning solutions, 3D printers, and milling machines. Complementing these are ceramic healing and screw-retained abutments, and a selection of preventative oral care products. A significant part of its portfolio is dedicated to biomaterials, including bone substitutes, specialized membranes, biologics, and products for soft tissue management and enhanced oral healing. Digital solutions extend to dental laboratories, clinics, and central milling facilities, supported by a range of materials, third-party system integrations, and guided surgery technologies. Its comprehensive surgical instrument catalog features modular and specialized cassettes, implant maintenance tools, bone block fixation sets, bonerings, and titanium pin sets. For patients with complete tooth loss (edentulous patients), Straumann provides specialized solutions like pro arch fixed prosthetics and mini implant systems. The company also focuses on aesthetic restorations, offering ceramic implant monotypes, ceramic implants, and various abutments, often enhanced by biologics. Its offerings further include the Clear Correct aligner system for orthodontic correction, and Emdogain, a product designed for wound healing. Beyond products, Straumann is committed to professional development, providing extensive training and educational services to its client base. Straumann's diverse clientele includes general dentists, dental specialists, and technicians working in laboratories. It also serves corporate entities such as distributors, hospitals, universities, and large dental service organizations. Its products reach customers in approximately 100 countries, facilitated by a robust network of direct distribution subsidiaries and strategic partners. Established in 1954, Straumann Holding AG maintains its corporate headquarters in Basel, Switzerland.

Straumann Holding AG is headquartered in CH.

Straumann Holding AG (SAUHY) stock trades at $11.88 with a market capitalization of $18.94B. The stock is valued at a price-to-earnings (P/E) ratio of 43.24, price-to-book of 7.13, price-to-sales of 5.95. Over the past 52 weeks the stock has ranged between $9.44 and $14.11, and currently trades 15.8% below its 52-week high. It pays a dividend yielding 1.09%.

On profitability, Straumann Holding AG generates a return on equity (ROE) of 16.90%, above the typical market average, return on capital employed of 17.50%, an operating margin of 20.65%, a net profit margin of 13.68%.

In its most recent fiscal year, Straumann Holding AG reported annual revenue of $2.6B, net profit of $356.0M, revenue has compounded at 12.8% a year over the last five years, profit at 31.4% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.30 — a conservative balance sheet with little leverage risk, a current ratio of 2.21, total assets of $3.8B, $476.0M in cash and equivalents.

SAUHY has an average daily trading volume of 79,055 shares, a beta of 1.39 (more volatile than the overall market).

Official website: www.straumann.com